Kazia therapeutics appoints john friend, md, as chief medical officer

Sydney, nov. 15, 2021 /prnewswire/ -- kazia therapeutics limited (nasdaq: kzia; asx: kza), an oncology-focused drug development company, is pleased to announce the appointment of john friend, md, as chief medical officer. in this role, dr. friend will be responsible for overseeing the development and commercialization of kazia's pipeline drug candidates, and for collaborating with clinicians and scientists to advance the company's research programs.
KZIA Ratings Summary
KZIA Quant Ranking